Infectious Diseases

The abrupt decision to revise the federal childhood vaccine schedule and a breakdown of some of the infectious diseases that these immunizations prevent.

Respiratory virus rates are climbing in the U.S. just in time for the holidays.

Many of this year’s biggest stories marked the beginning of—or turning points for—important public health issues.

Malaria treatment has relied on artemisinin for decades—amid rising resistance, another option is on the horizon. But how should it be used?

Small proof-of-principle study using samples from Baltimore sidewalks suggests fungi developing heat tolerance in city settings

Certain vaccines may reduce your chances of heart attack, stroke, or dementia—and they can save you money.

Amid conflict and U.S. cuts, MSF clinics in Yemen see vaccine-preventable diseases “on a daily basis.” 

O'Neal is an immunologist and vector biologist who studies how ticks acquire and transmit human pathogens, including the causative agent of Lyme disease.

Hepatitis B vaccines are the best way to protect vulnerable infants from developing chronic, life-threatening disease.

The miraculous power of penicillin and other antibiotics has been threatened by decades of rampant overuse.

Pathogens passed from animals to humans can trigger outbreaks like those of COVID-19 or Ebola. One Health offers a holistic approach to stopping these spillovers at their source.

Anti-malaria programs, largely focused on vector control, have saved many millions of lives—albeit with recent gains now threatened—since the moment in 1897 when the India Medical Service’s Ronald Ross demonstrated that the “dapple winged mosquito” and not miasmatic “bad air” was the vehicle of malaria transmission.

mRNA vaccine technology has huge potential for treating not just infectious diseases but cancer and many chronic diseases—advances that may be threatened by funding cuts.